chr22-50225883-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_020461.4(TUBGCP6):c.1894G>C(p.Glu632Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000991 in 1,613,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020461.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBGCP6 | NM_020461.4 | c.1894G>C | p.Glu632Gln | missense_variant | Exon 10 of 25 | ENST00000248846.10 | NP_065194.3 | |
TUBGCP6 | XR_001755343.3 | n.2458G>C | non_coding_transcript_exon_variant | Exon 10 of 20 | ||||
TUBGCP6 | XR_007067982.1 | n.2458G>C | non_coding_transcript_exon_variant | Exon 10 of 19 | ||||
TUBGCP6 | XR_938347.3 | n.2458G>C | non_coding_transcript_exon_variant | Exon 10 of 23 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152018Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000876 AC: 22AN: 251166Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135798
GnomAD4 exome AF: 0.0000999 AC: 146AN: 1461784Hom.: 0 Cov.: 30 AF XY: 0.0000784 AC XY: 57AN XY: 727210
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152136Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74372
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1894G>C (p.E632Q) alteration is located in coding exon 10 of the TUBGCP6 gene. This alteration results from a G to C substitution at nucleotide position 1894, causing the glutamic acid (E) at amino acid position 632 to be replaced by a glutamine (Q). Based on data from gnomAD, the C allele has an overall frequency of 0.01% (24/282528) total alleles studied. The highest observed frequency was 0.03% (2/7214) of Other alleles. This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Microcephaly and chorioretinopathy 1 Uncertain:1
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
not provided Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 632 of the TUBGCP6 protein (p.Glu632Gln). This variant is present in population databases (rs199582514, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TUBGCP6-related conditions. ClinVar contains an entry for this variant (Variation ID: 521246). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at